BIO Digital

June 8-12, 2020

Recap: Leveraging Innovative Technologies to Treat COVID-19 Patients

Search General Info
Search Education
Search Partnering Companies

Recap: Leveraging Innovative Technologies to Treat COVID-19 Patients

As the consequences of COVID-19 infection have been felt around the world, companies moved swiftly to test many of the products in their pipelines against SARS CoV2, the virus that causes COVID-19, as well as the complex set of complications associated with the virus. This has led to a broad array of novel approaches to treating patients infected with the virus, from antibodies that could be given as prevention or treatment to products that help reduce the impact of the cytokine storm and treat Acute Respiratory Distress Syndrome (ARDS), severe inflammation, and secondary bacterial infections.

Our panelists and industry experts discussed the development of these vital treatment options and how partnerships between industry, governments and NGOs will help speed the availability of new medicines that benefit patients.

Below is a social recap of the session:

Leveraging Innovative Technology to Treat COVID-19 Patients